Method for the treatment of thromboembolism
AssigneeBoston Scientific Scimed, Inc.
InventorLynn Gourley Allen
Life of this patent
Estimating the term…
Abstract
A method for the treatment of thromboembolism comprising administering a thrombolytic agent directly to the thromboembolism in the presence of ultrasound. The total dose of thrombolytic agent administered is between 1 and 12 mg and the time over which the total dose is delivered is less than 15 hours.
Claims20
A method for a treatment of a thromboembolism comprising administering to a human subject a thrombolytic agent directly to the thromboembolism in a presence of ultrasound, wherein a total dose of the thrombolytic agent administered is between 2 and 6 mg and the total dose of thrombolytic agent is delivered over a period of time, wherein the period of time is a minimum of 30 minutes and a maximum of 6 hours.
A method for a treatment of a thromboembolism comprising administering to a human subject a thrombolytic agent directly to the thromboembolism in a presence of ultrasound, wherein a total dose of the thrombolytic agent administered is between 1 and 12 mg and the total dose of thrombolytic agent is delivered over a period of time, wherein the period of time is a minimum of 30 minutes and a maximum of 6 hours;
- and
- wherein the thrombolytic agent is infused at rate of 1 mg/hour.
Dependencies are inferred from the claim text.